InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nurix Therapeutics, Inc.

NRIX Clue Score49
United States Fiscal year ends November CIK 0001549595 Results filed 13 Oct 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Gwenn Hansen
2 Nov 2026
Chief Scientific Officer
Sold after exercise
1,452
$26.80
$38.91K
Christine Ring
2 Nov 2026
Chief Legal Officer
Sold after exercise
1,075
$26.76
$28.77K
Christine Ring
2 Nov 2026
Chief Legal Officer
Sold after exercise
9,527
$25.74
$245.22K
Gwenn Hansen
30 Oct 2026
Chief Scientific Officer
Sold after exercise
3,957
$26.28
$103.99K
Christine Ring
30 Oct 2026
Chief Legal Officer
Sold after exercise
3,957
$26.28
$103.99K
Houte Hans van
30 Oct 2026
Chief Financial Officer
Sold after exercise
2,834
$26.28
$74.47K
Gwenn Hansen
15 Oct 2026
Chief Scientific Officer
Sold after exercise
1,452
$25.00
$36.30K
Julia P Gregory
14 Oct 2026
Director
Sold after exercise
22,583
$23.40
$528.53K
Show all 11 transactions →

What was left out

Form 4 filings counted 7
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 8
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 61,819
History held since 29 Jul 2020